The bacterial microbiota of Hunner lesion interstitial cystitis/bladder pain syndrome

被引:7
|
作者
Nickel, J. Curtis [1 ]
Ehrlich, Garth D. [2 ]
Krol, Jaroslaw E. [2 ]
Ahmed, Azad [2 ]
Sen, Bhaswati [2 ]
Bhat, Archana [2 ]
Mell, Joshua C. [2 ]
Doiron, R. Christopher [1 ]
Kelly, Kerri-Lynn [1 ]
Earl, Joshua P. [2 ]
机构
[1] Queens Univ, Dept Urol, Kingston, ON, Canada
[2] Drexel Univ, Dept Microbiol & Immunol, Philadelphia, PA 19104 USA
基金
加拿大健康研究院;
关键词
Hunner lesion; interstitial cystitis; bladder pain syndrome; microbiome; infection; urinary tract infection; SYNDROME/INTERSTITIAL CYSTITIS; DISTINCT; WOMEN;
D O I
10.1111/bju.15519
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Objective To undertake the first comprehensive evaluation of the urinary microbiota associated with Hunner lesion (HL) interstitial cystitis/bladder pain syndrome (IC/BPS). Despite no previous identification of a distinct IC/BPS microbial urotype, HL IC/BPS, an inflammatory subtype of IC/BPS, was hypothesized most likely to be associated with a specific bacterial species or microbial pattern. Participants and Methods The bacterial microbiota of midstream urine specimens from HL IC/BPS and age- and gender-matched IC/BPS patients without HL (non-HL IC/BPS) were examined using the pan-bacterial domain clinical-level molecular diagnostic Pacific Biosciences full-length 16S gene sequencing protocol, informatics pipeline and database. We characterized the differential presence, abundances, and diversity of species, as well as gender-specific differences between and among HL and non-HL IC/BPS patients. Results A total of 59 patients with IC/BPS were enrolled (29 HL, 30 non-HL; 43 women, 16 men) from a single centre and the microbiota in midstream urine specimens was available for comparison. The species abundance differentiation between the HL and non-HL groups (12 species) was not significantly different after Bonferroni adjustments for multiple comparisons. Similarly, the nine differentiating species noted between female HL and non-HL patients were not significantly different after similar statistical correction. However, four species abundances (out of the 10 species differences identified prior to correction) remained significantly different between male HL and non-HL subjects: Negativicoccus succinivorans, Porphyromonas somerae, Mobiluncus curtisii and Corynebacterium renale. Shannon diversity metrics showed significantly higher diversity among HL male patients than HL female patients (P = 0.045), but no significant diversity differences between HL and non-HL patients overall. Conclusions We were not able to identify a unique pathogenic urinary microbiota that differentiates all HL from all non-HL IC/BPS. It is likely that the male-specific differences resulted from colonization/contamination remote from the bladder. We were not able to show that bacteria play an important role in patients with HL IC/BPS.
引用
收藏
页码:104 / 112
页数:9
相关论文
共 50 条
  • [41] The Efficacy of Micro-Radiofrequency Therapy for Treating Non-Hunner Lesion Interstitial Cystitis/Bladder Pain Syndrome: A Retrospective Cohort Study
    Zhao, Chesong
    Li, Pu
    Wang, Chengming
    Liu, Jin
    Xue, Luotong
    Zhang, Yurong
    Meng, Xiaoxin
    Tang, Min
    INTERNATIONAL UROGYNECOLOGY JOURNAL, 2025, 36 (01) : 213 - 220
  • [42] Hunner Lesion Interstitial Cystitis: The Bad, The Good, and The Unknown
    Nickel, J. Curtis
    Doiron, R. Christopher
    EUROPEAN UROLOGY, 2020, 78 (03) : 122 - 124
  • [43] The impact of Hunner lesion-type interstitial cystitis/bladder pain syndrome on health-related quality of life and the effects of transurethral ablation
    Kwang Jin Ko
    Jihyun Lim
    Jiwoong Yu
    Danbee Kang
    Juhee Cho
    Kyu-Sung Lee
    Quality of Life Research, 2022, 31 : 3221 - 3228
  • [44] The impact of Hunner lesion-type interstitial cystitis/bladder pain syndrome on health-related quality of life and the effects of transurethral ablation
    Ko, Kwang Jin
    Lim, Jihyun
    Yu, Jiwoong
    Kang, Danbee
    Cho, Juhee
    Lee, Kyu-Sung
    QUALITY OF LIFE RESEARCH, 2022, 31 (11) : 3221 - 3228
  • [45] Cyclosporine for the treatment of hunner's lesion interstitial cystitis
    Tennyson, Lauren
    Turner, Kate
    Vollstedt, Annah
    Peters, Kenneth
    NEUROUROLOGY AND URODYNAMICS, 2020, 39 : S141 - S142
  • [46] Interstitial Cystitis/Bladder Pain Syndrome Is Imprecise: Time to Cleave Into Interstitial Cystitis and Bladder Pain Syndrome as Separate Conditions
    Donohoo, Nancy
    Orlando, Andrew
    Chai, Toby C.
    JOURNAL OF UROLOGY, 2024, 212 (01): : 223 - 224
  • [47] ANALYSIS OF URINE MARKERS IN PATIENTS WITH INTERSTITIAL CYSTITIS/BLADDER PAIN SYNDROME AND CHRONIC BACTERIAL CYSTITIS
    Furuta, A.
    Yamamoto, T.
    Suzuki, Y.
    Gotoh, M.
    Egawa, S.
    Yoshimura, N.
    NEUROUROLOGY AND URODYNAMICS, 2016, 35 : S280 - S281
  • [48] Biomarkers for Bladder Pain Syndrome/Interstitial Cystitis
    Charrua, Ana
    Mendes, Pedro
    Cruz, Celia
    CURRENT BLADDER DYSFUNCTION REPORTS, 2021, 16 (01) : 12 - 18
  • [49] Pathophysiology of interstitial cystitis/bladder pain syndrome
    Ke, Qian-Shen
    Kuo, Hann-Chorng
    TZU CHI MEDICAL JOURNAL, 2015, 27 (04): : 139 - 144
  • [50] Management of interstitial cystitis/bladder pain syndrome
    Cox, Ashley
    CUAJ-CANADIAN UROLOGICAL ASSOCIATION JOURNAL, 2018, 12 (06): : S157 - S160